Raymond James Financial
MRK icon

Raymond James Financial’s Merck MRK Stock Holding History

Raymond James Financial’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,000
Closed -$600K – 6050
2025
Q2 		$600K Buy
+8,000
New +$636K ﹤0.01% 3898

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Raymond James Financial's MRK Position: Q1 2026 in Review

Raymond James Financial reduced its Merck (MRK) stake by 5% in Q1 2026, selling an estimated $39.6M and leaving 6,585,514 shares worth $792M. The position accounts for 0.24% of the portfolio, ranked #70.

Raymond James Financial first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.56B in Q4 2024. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Raymond James Financial held 6,585,514 shares of Merck worth $792M as of Q1 2026.
  • Raymond James Financial sold 343,142 Merck shares in Q1 2026, an estimated $39.6M.
  • Merck made up 0.24% of Raymond James Financial's portfolio in Q1 2026, its #70 holding.
  • Raymond James Financial first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Merck position peaked at $1.56B in Q4 2024.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.